U.S. Markets open in 5 hrs 3 mins

Sanofi (SNY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
48.08-0.35 (-0.72%)
At close: 4:02PM EDT
People also watch
NVSGSKAZNLLYNVO
Full screen
Previous Close48.43
Open48.72
Bid47.88 x 2200
Ask47.94 x 3700
Day's Range48.08 - 48.82
52 Week Range36.81 - 50.24
Volume572,158
Avg. Volume1,674,320
Market Cap117.58B
Beta0.75
PE Ratio (TTM)11.63
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.64 (3.39%)
Ex-Dividend Date2017-05-11
1y Target EstN/A
Trade prices are not sourced from all markets
  • EpiPen maker finalizes settlement for government overcharges
    Associated Press12 hours ago

    EpiPen maker finalizes settlement for government overcharges

    TRENTON, N.J. (AP) — EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade — charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government.

  • American City Business Journals16 hours ago

    EpiPen maker settles federal claims for $465M a year after Sanofi filed suit

    Mylan NV will pay $465 million fine to settle claims brought by the U.S. Justice Department that it overcharged the government for its emergency allergy drug, EpiPen. French drug company Sanofi, the parent company of the state’s largest biotech employer, Sanofi Genzyme (SNY), first brought the matter to the attention of the U.S. Attorney’s Office in 2014 because it was selling a competing epinephrine auto-injector drug called AUVI-Q. In 2016, Sanofi filed a complaint in Massachusetts federal court against Mylan under the False Claims Act, which permits private parties to sue on behalf of the government and to receive a share of any recovery.

  • TheStreet.com16 hours ago

    Mylan Finalizes $465 Million EpiPen Settlement With DoJ

    The dispute became the center of a drug price firestorm.